FilingSEC EDGAR8-K
Inhibikase Therapeutics Files Updated Corporate Presentation
· SEC accepted
StageFiling
Filing content
Inhibikase Therapeutics filed an updated corporate presentation as an exhibit to its Form 8-K for use in meetings with investors and analysts.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…